Saturday, 31 October 2026European Markets

THALES And SAFRAN Have A High Dividend Yield And Return On Equity In The Aerospace & Defense Industry.

Loading stream...

(vianews) - thales (ho.pa) is among this list of stock assets with the highest dividend rate and return on equity on the aerospace & defense industry.

financial asset price forward dividend yield return on equity
thales (ho.pa) €136.65 2.08% 15.78%
safran (saf.pa) €152.04 0.89% 30.34%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. thales (ho.pa)

2.08% forward dividend yield and 15.78% return on equity

thales s.a. provides various solutions for civilian and military customers in the defence and security, aerospace and space, digital identity and security, and transport markets worldwide. it operates through aerospace, defence & security, digital identity & security, and ground transportation systems business segments. the company offers communications, command, and control systems; mission services and support; protection and mission/combat systems; surveillance, detection, and intelligence systems; training and simulation solutions for air, land, naval, and joint forces; and digital identity and security solutions. it also provides air traffic management solutions; flight decks and avionics equipment and functions; in-flight entertainment and connectivity systems and services; electrical systems; aerospace trading solutions; navigation solutions; support and services for avionics equipment; and connectivity solutions. in addition, the company designs, operates, and delivers satellite-based systems for telecommunications, navigation, earth observation, environmental management, exploration, and science and orbital infrastructures; signaling, communications and supervision, and fare collection management systems and related services; cybersecurity and railway digitalization systems; and main line rail, and urban and intermodal mobility solutions. further, it provides solutions for various markets and applications, including radiology, radio frequency, microwave sources, training and simulation solutions, lasers, and microelectronics solutions for science, industry, space, defense, automotive, railways, and energy conversion platforms. the company was formerly known as thomson-csf and changed its name to thales s.a. in 2000. thales s.a. was founded in 1893 and is headquartered in courbevoie, france.

earnings per share

as for profitability, thales has a trailing twelve months eps of €5.58.

pe ratio

thales has a trailing twelve months price to earnings ratio of 24.49. meaning, the purchaser of the share is investing €24.49 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.78%.

volume

today's last reported volume for thales is 59966 which is 72.03% below its average volume of 214427.

dividend yield

as maintained by morningstar, inc., the next dividend payment is on may 23, 2023, the estimated forward annual dividend rate is 2.94 and the estimated forward annual dividend yield is 2.08%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, thales's stock is considered to be oversold (<=20).

moving average

thales's worth is above its 50-day moving average of €136.31 and above its 200-day moving average of €133.65.

more news about thales.

2. safran (saf.pa)

0.89% forward dividend yield and 30.34% return on equity

safran sa, together with its subsidiaries, engages in the aerospace and defense businesses worldwide. the company operates through three segments: aerospace propulsion; aircraft equipment, defense and aerosystems; and aircraft interiors. the aerospace propulsion segment designs, develops, produces, and markets propulsion and mechanical power transmission systems for commercial aircraft, military transport, training and combat aircraft, civil and military helicopters, satellites, and drones; and offers maintenance, repair, and overhaul services, as well as sells spare parts. the aircraft equipment, defense and aerosystems segment provides landing gears and brakes; nacelles and reversers; avionics, such as flight controls and onboard information systems; security systems, including evacuation slides and oxygen masks; onboard computers and fuel systems; electrical power management systems and related engineering services; and optronic equipment and sights, navigation equipment and sensors, infantry, and drones, as well as sells spare parts. the aircraft interiors segment designs, develops, manufactures, and markets aircraft seats for passengers and crew; cabin equipment, overhead bins, class dividers, passenger service units, cabin interior solutions, chilling systems, galleys, electrical inserts, and trolleys and cargo equipment; and water distribution equipment, lavatories, air systems, and in-flight entertainment and connectivity systems. its products and services are used in civil and military aircraft, and helicopters. the company was incorporated in 1924 and is based in paris, france.

earnings per share

as for profitability, safran has a trailing twelve months eps of €7.34.

pe ratio

safran has a trailing twelve months price to earnings ratio of 20.71. meaning, the purchaser of the share is investing €20.71 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 30.34%.

revenue growth

year-on-year quarterly revenue growth grew by 28.3%, now sitting on 22.13b for the twelve trailing months.

more news about safran.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com